163 related articles for article (PubMed ID: 23361235)
21. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
22. Parafibromin Abnormalities in Ossifying Fibroma.
Costa-Guda J; Pandya C; Strahl M; Taik P; Sebra R; Chen R; Uzilov AV; Arnold A
J Endocr Soc; 2021 Jul; 5(7):bvab087. PubMed ID: 34159287
[TBL] [Abstract][Full Text] [Related]
23. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Cetani F; Ambrogini E; Viacava P; Pardi E; Fanelli G; Naccarato AG; Borsari S; Lemmi M; Berti P; Miccoli P; Pinchera A; Marcocci C
Eur J Endocrinol; 2007 May; 156(5):547-54. PubMed ID: 17468190
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical assessment of parafibromin in mouse and human tissues.
Porzionato A; Macchi V; Barzon L; Masi G; Iacobone M; Parenti A; Palù G; De Caro R
J Anat; 2006 Dec; 209(6):817-27. PubMed ID: 17118068
[TBL] [Abstract][Full Text] [Related]
25. HRPT2 gene analysis and the diagnosis of parathyroid carcinoma.
Cetani F; Pardi E; Banti C; Borsari S; Ambrogini E; Vignali E; Cianferotti L; Viccica G; Pinchera A; Marcocci C
Expert Rev Endocrinol Metab; 2008 May; 3(3):377-389. PubMed ID: 30754207
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract][Full Text] [Related]
27. Analysis of aberrantly spliced HRPT2 transcripts and the resulting proteins in HPT-JT syndrome.
Moon S; Kim JH; Shim JY; Ahn YB; Song KH; Cha BY; Maeng LS; Han JH
Mol Genet Metab; 2010 Aug; 100(4):365-71. PubMed ID: 20541447
[TBL] [Abstract][Full Text] [Related]
28. Parafibromin inhibits cancer cell growth and causes G1 phase arrest.
Zhang C; Kong D; Tan MH; Pappas DL; Wang PF; Chen J; Farber L; Zhang N; Koo HM; Weinreich M; Williams BO; Teh BT
Biochem Biophys Res Commun; 2006 Nov; 350(1):17-24. PubMed ID: 16989776
[TBL] [Abstract][Full Text] [Related]
29. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
[TBL] [Abstract][Full Text] [Related]
30. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
Wang CC; Mao TL; Yang WC; Jeng YM
Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
32. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
33. The clinicopathological and prognostic significances of CDC73 expression in breast cancer: A pathological and bioinformatics analysis.
E Y; Xue H; Zhang CY; Zhao MZ; Zheng HC
Histol Histopathol; 2023 Apr; 38(4):453-465. PubMed ID: 36255176
[TBL] [Abstract][Full Text] [Related]
34. Differential radiologic characteristics of renal tumours on multiphasic computed tomography.
Ching BC; Tan HS; Tan PH; Toh CK; Kanesvaran R; Ng QS; Tan MH
Singapore Med J; 2017 May; 58(5):262-266. PubMed ID: 27090599
[TBL] [Abstract][Full Text] [Related]
35. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy.
Larrinaga G; Valdivia A; Arrieta-Aguirre I; Solano-Iturri JD; Ugalde-Olano A; Loizaga-Iriarte A; Santos-Martín A; Pérez-Fernández A; Angulo JC; López JI
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338778
[TBL] [Abstract][Full Text] [Related]
36. Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.
Rasti A; Abolhasani M; Zanjani LS; Asgari M; Mehrazma M; Madjd Z
J Cancer Res Clin Oncol; 2017 Jan; 143(1):95-104. PubMed ID: 27638770
[TBL] [Abstract][Full Text] [Related]
37. Renal neoplasia in the hyperparathyroidism-jaw tumor syndrome.
Tan MH; Teh BT
Curr Mol Med; 2004 Dec; 4(8):895-7. PubMed ID: 15579037
[TBL] [Abstract][Full Text] [Related]
38. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
[TBL] [Abstract][Full Text] [Related]
39. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.
Shen DF; Liu X; Yang XF; Fang L; Gao Y; Zhao S; Wu JC; Shi S; Li JJ; Zhao XX; Gou WF; Zheng HC
Tumour Biol; 2016 Mar; 37(3):2909-24. PubMed ID: 26409451
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of subtypes of renal cell carcinoma with contrast-enhanced ultrasonography.
Xue LY; Lu Q; Huang BJ; Li CX; Yan LX; Wang WP
Clin Hemorheol Microcirc; 2016 Oct; 63(4):361-371. PubMed ID: 26598999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
